
neuro42 is a pioneering company transforming neurological care through its portable MRI and AI-powered neurosurgical robotics platform. The company offers an FDA 510(k) cleared portable MRI system designed to bring advanced neuroimaging directly to the point-of-care, enabling faster diagnosis and targeted treatments with minimal patient disruption. Their technology supports safer, minimally invasive procedures with interventional guidance and integrates care by allowing seamless transitions from diagnosis to intervention in one location. Backed by over 40 patents and led by a team of experienced entrepreneurs and medical experts, neuro42 is positioned as an innovator in accessible, patient-centered neuroimaging solutions with growing adoption in clinical and sports settings.

neuro42 is a pioneering company transforming neurological care through its portable MRI and AI-powered neurosurgical robotics platform. The company offers an FDA 510(k) cleared portable MRI system designed to bring advanced neuroimaging directly to the point-of-care, enabling faster diagnosis and targeted treatments with minimal patient disruption. Their technology supports safer, minimally invasive procedures with interventional guidance and integrates care by allowing seamless transitions from diagnosis to intervention in one location. Backed by over 40 patents and led by a team of experienced entrepreneurs and medical experts, neuro42 is positioned as an innovator in accessible, patient-centered neuroimaging solutions with growing adoption in clinical and sports settings.